Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
44
FOLD Quote, Financials, Valuation and Earnings
Last price:
$9.81
Seasonality move
:
5.47%
Day range:
$9.60 - $9.88
52-week range:
$9.02 - $14.57
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.02x
P/B ratio:
16.38x
Volume:
3.5M
Avg. volume:
2.6M
1-year change:
-23.68%
Market cap:
$2.9B
Revenue:
$399.4M
EPS (TTM):
-$0.34
Earnings Data
Next earnings date for FOLD
Feb 28
2025
Most recent earnings per share
-$0.02
Missed by $0.07
(Nov 6/2024)
Consensus Estimate
$0.05
(Nov 6/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
FOLD Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/28/2025 | Q4 | $147.4M | -- | -- | $0.08 | -- |
| 11/06/2024 | Q3 | $135M | $141.5M | -$0.02 | $0.05 | -$0.07 |
| 08/08/2024 | Q2 | $121.2M | $126.7M | -$0.05 | $0.02 | -$0.07 |
| 05/09/2024 | Q1 | $111.2M | $110.4M | -$0.16 | -$0.03 | -$0.13 |
| 02/28/2024 | Q4 | $115M | $115.1M | -$0.11 | -$0.04 | -$0.07 |
| 11/08/2023 | Q3 | -- | -- | -$0.07 | -$0.08 | $0.01 |
| 08/08/2023 | Q2 | -- | -- | -$0.15 | -$0.11 | -$0.04 |
| 05/10/2023 | Q1 | -- | -- | -$0.18 | -$0.14 | -$0.04 |
| 03/01/2023 | Q4 | -- | -- | -$0.19 | -$0.14 | -$0.05 |
| 11/07/2022 | Q3 | -- | -- | -$0.12 | -$0.19 | $0.07 |
| 08/04/2022 | Q2 | -- | -- | -$0.21 | -$0.22 | $0.01 |
| 05/09/2022 | Q1 | -- | -- | -$0.30 | -$0.29 | -$0.01 |
| 02/24/2022 | Q4 | -- | -- | -$0.29 | -$0.16 | -$0.13 |
| 11/09/2021 | Q3 | -- | -- | -$0.19 | -$0.18 | -$0.01 |
| 08/05/2021 | Q2 | -- | -- | -$0.19 | -$0.20 | $0.01 |
| 05/10/2021 | Q1 | -- | -- | -$0.25 | -$0.26 | $0.01 |
| 03/01/2021 | Q4 | -- | -- | -$0.27 | -$0.22 | -$0.06 |
| 11/05/2020 | Q3 | -- | -- | -$0.25 | -$0.20 | -$0.05 |
| 08/10/2020 | Q2 | -- | -- | -$0.20 | -$0.26 | $0.06 |
| 05/07/2020 | Q1 | -- | -- | -$0.35 | -$0.25 | -$0.10 |
| 03/02/2020 | Q4 | -- | -- | -$0.35 | -$0.26 | -$0.09 |
| 11/11/2019 | Q3 | -- | -- | -$0.24 | -$0.32 | $0.08 |
| 08/08/2019 | Q2 | -- | -- | -$0.36 | -$0.34 | -$0.03 |
| 05/08/2019 | Q1 | -- | -- | -$0.56 | -$0.31 | -$0.25 |
| 02/28/2019 | Q4 | -- | -- | -$0.41 | -- | -- |
| 11/05/2018 | Q3 | -- | -- | -$0.84 | -- | -- |
| 08/07/2018 | Q2 | -- | -- | -$0.33 | -- | -- |
| 05/08/2018 | Q1 | -- | -- | -$0.28 | -- | -- |
| 02/28/2018 | Q4 | -- | -- | -$0.41 | -- | -- |
| 11/08/2017 | Q3 | -- | -- | -$0.69 | -- | -- |
| 08/07/2017 | Q2 | -- | -- | -$0.34 | -- | -- |
| 05/09/2017 | Q1 | -- | -- | -$0.39 | -- | -- |
| 03/01/2017 | Q4 | -- | -- | -$0.42 | -- | -- |
| 11/07/2016 | Q3 | -- | -- | -$0.33 | -- | -- |
| 08/09/2016 | Q2 | -- | -- | -$0.40 | -- | -- |
| 05/03/2016 | Q1 | -- | -- | -$0.35 | -- | -- |
| 02/26/2016 | Q4 | -- | -- | -$0.35 | -- | -- |
| 11/03/2015 | Q3 | -- | -- | -$0.32 | -- | -- |
| 08/05/2015 | Q2 | -- | -- | -$0.27 | -- | -- |
| 05/05/2015 | Q1 | -- | -- | -$0.25 | -- | -- |
| 03/03/2015 | Q4 | -- | -- | -$0.24 | -- | -- |
Amicus Therapeutics Earnings Questions
-
How Much did Amicus Therapeutics Generate in Revenue Last Quarter?
Amicus Therapeutics reported $141.5M worth of top line sales in its most recent quarter.
-
Did Amicus Therapeutics Beat Earnings Last Quarter?
Amicus Therapeutics announced earnings per share of -$0.02 which represents a miss of analyst forecast a $0.05 per share.
-
Is Amicus Therapeutics Profitable?
Amicus Therapeutics reported $128.2M that represents $0.42 per share over the last quarter.
-
What is the Analyst Consensus for Amicus Therapeutics EPS Next Year?
Amicus Therapeutics's earnings are forecast to decrease from -$0.51 per share to -$0.40 per share next year representing a decrease of -50.71%.
-
When is Amicus Therapeutics's Earnings Date?
Amicus Therapeutics's next earnings date is February 28, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
